Clinical Trial Update: A Phase 2/3,PSMA-T4, Prostate Cancer [NA]

View source ↗

Summary

A Phase 2/3 clinical trial update investigating PSMA-T4 for prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PSMA-T4

Snippet

Sponsor: NCBJ Polatom: Narodowe Centrum Badań Jądrowych Polatom | Conditions: Prostate Cancer | NA | Status: RECRUITING